期刊文献+

小剂量乙胺碘呋酮治疗快速性异位心律失常的远期疗效

Long-term effects of Low-dose Amiodarone in patients with achyarrhythmia
下载PDF
导出
摘要 目的观察小剂量乙胺碘呋酮治疗快速性异位心律失常的远期疗效及安全性。方法将快速性异位心律失常患者80例随机分为两组:观察组小剂量维持治疗,乙胺碘呋酮剂量为每日20mg/kg,连用7日后,改为每日100mg,服用12个月。对照组大剂量负荷治疗,乙胺碘呋酮剂量为每日20mg/kg,连续服药6周,随访期间心律失常复发者重复以上治疗。观察用药后室性早搏数目和短阵室速发作时间,观察体表心电图12导联的Q-T间期及QT离散度变化;记录毒副作用的发生率。结果观察组有效率为88.6%,对照组有效率为22.2%,两组相比P<0.01;观察组治疗后ECG中Q-T间期为(480±38)ms,对照组为(540±28)ms,两组相比P<0.05;观察组毒副作用的发生率为13.5%,对照组为79.3%,两组相比P<0.05。结论小剂量乙胺碘呋酮维持疗法在快速性异位心律失常的治疗中高效、安全、副作用少,值得推广使用。 Objective To observe the long--term effects and safety of low--dose amiodarone in patients with achyarrhythmia. Methods 80 cases with achyarrhythmia were randomly divided into two groups: the treatment group (44 eases,amiodarone, 20 mg/kg×7 days, then, 100mg per day for 12 months)and the control group(36 cases, amiodarone, 20 mg/kg per day for 6 weeks, arrhythmia recur- rence repeat the above treatment). The number of premature ventricular contractions,ventrieular taehycardia burst time and the QT interval of 12-lead surface ECG were observed, the incidence of side effects was recorded. Results In the treatment group, the effectiveness rate, the incidence of toxic and side effect and the QT interval were 88.6%, 13.3%, 480 ± 38ms, in the control group, were separately 22. 2%, 79.3% and 540±28ms, there was a significant difference between the two groups (P 〈 0.05or P 〈 0.01). Conclusions The treatment of low--dose amiodarone in patients with achyarrhythmia was efficient, safe,less side effects, which is quite worthy of popularization.
作者 张卉 李振英
出处 《齐齐哈尔医学院学报》 2009年第15期1824-1825,共2页 Journal of Qiqihar Medical University
关键词 乙胺碘呋酮 心律失常 毒副作用 Amiodarone Arrhythmia Toxic and side effect
  • 相关文献

参考文献5

  • 1Braunwald.心脏病学[M].北京:人民卫生出版社,2003:558-559.
  • 2刘国仗,胡大一,陶萍,等.心血管药物临床试验评价方法的建议[J].中华心血管杂志,2006,16(1):56-62.
  • 3胡琛 陈国伟.胺碘酮抗心律失常的新认识.国外医学:内科学分册,2006,2:66-69.
  • 4吕蓓,龚兰生.小剂量乙胺碘呋酮维持房颤复律后窦性心律的疗效[J].上海第二医科大学学报,2002,22(4):379-380. 被引量:1
  • 5Doffrell SA. Amiodarone--waxed and waned and waxed again [J].Expert Opin Pharmacother, 2007,2 ( 11 ) : 1 877-- 1 890.

二级参考文献3

  • 1[1]Erie NP. Cardioversion of atrial fibrillation to sinus rhythm: who, when, how and why[J]? Am J Cardiol, 2000,86:326-327.
  • 2[2]The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction [J]. N Engl J Med, 1989, 321:406-412.
  • 3[3]Kowey PR, Marinchak RA, Rials SJ, et al. Pharmacologic and pharmacokinetic profile of class Ⅲ antiarrhythmic drugs[J]. Am J Cardiol, 1997, 23:16G-23G.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部